CM
Caption Management Portfolio holdings
AUM $1.09B
1-Year Return
4.13%
This Quarter Return
+2.11%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$1.09B
AUM Growth
-$1.1B
(-50%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-110.09%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,115
New
230
Increased
115
Reduced
111
Closed
247
Top Buys
| 1 |
Insmed
INSM
|
+$21.2M |
| 2 |
SKX
Skechers
SKX
|
+$20.1M |
| 3 |
Gilead Sciences
GILD
|
+$16.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 5 |
Kellanova
K
|
+$14.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$394M |
| 2 |
Amazon
AMZN
|
+$314M |
| 3 |
NVIDIA
NVDA
|
+$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$130M |
| 5 |
Cisco
CSCO
|
+$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.45% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ardelyx
ARDX
$1.49B
| $512K | 0.01% |
+130,500
| New | +$512K |
|
|
VRNA
327
Verona Pharma
VRNA
$9.19B
| $506K | 0.01% |
+5,351
| New | +$506K |
|
328
Kilroy Realty
KRC
$5.17B
| $496K | 0.01% |
14,443
-557
| -4% | -$19.1K |
|
329
Nuvalent
NUVL
$5.67B
| $491K | 0.01% |
+6,438
| New | +$491K |
|
330
Snap
SNAP
$13.5B
| $491K | 0.01% |
+56,500
| New | +$491K |
|
331
Agilon Health
AGL
$472M
| $483K | 0.01% |
210,000
| – | – |
|
332
Keros Therapeutics
KROS
$634M
| $482K | 0.01% |
36,078
-70,903
| -66% | -$947K |
|
333
Rhythm Pharmaceuticals
RYTM
$6.38B
| $476K | 0.01% |
+7,540
| New | +$476K |
|
334
OppFi Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OPFI.WS
$65.8M
| $475K | 0.01% |
+111,000
| New | +$475K |
|
335
Klaviyo
KVYO
$10.1B
| $469K | 0.01% |
13,962
| – | – |
|
336
CommScope
COMM
$3.61B
| $455K | 0.01% |
+55,000
| New | +$455K |
|
337
Guess, Inc.
GES
$870M
| $453K | 0.01% |
+37,434
| New | +$453K |
|
338
Nu Holdings
NU
$77.1B
| $451K | 0.01% |
32,900
-212,100
| -87% | -$2.91M |
|
339
Viatris
VTRS
$11.2B
| $451K | 0.01% |
+50,500
| New | +$451K |
|
340
Rumble
RUM
$2.55B
| $449K | 0.01% |
+50,000
| New | +$449K |
|
341
CryoPort
CYRX
$444M
| $448K | 0.01% |
+60,004
| New | +$448K |
|
342
Mineralys Therapeutics
MLYS
$2.89B
| $446K | ﹤0.01% |
+33,000
| New | +$446K |
|
343
Sweetgreen
SG
$1.03B
| $446K | ﹤0.01% |
+30,000
| New | +$446K |
|
344
Rezolute
RZLT
$671M
| $446K | ﹤0.01% |
100,000
+50,098
| +100% | +$223K |
|
345
Lithia Motors
LAD
$8.54B
| $439K | ﹤0.01% |
1,300
-400
| -24% | -$135K |
|
346
Apogee Therapeutics
APGE
$2.24B
| $436K | ﹤0.01% |
10,029
+7,614
| +315% | +$331K |
|
|
PGRE
347
Paramount Group
PGRE
$1.44B
| $427K | ﹤0.01% |
+70,000
| New | +$427K |
|
348
Dave & Buster's
PLAY
$732M
| $426K | ﹤0.01% |
14,153
+12,200
| +625% | +$367K |
|
349
Uranium Energy
UEC
$5.44B
| $425K | ﹤0.01% |
62,500
+20,720
| +50% | +$141K |
|
350
Capri Holdings
CPRI
$2.6B
| $425K | ﹤0.01% |
+24,000
| New | +$425K |
|